ASCRS 2023: Analysis in two subgroups of routine cataract surgery

Video

Edward Hu, MD, PhD, discussed his paper on the single surgeon retrospective comparative analysis of 517 eyes of two subgroups of routine cataract surgery at the 2023 ASCRS annual meeting in San Diego.

Video transcript

Editor’s note: Transcript lightly edited for clarity.

Edward Hu, MD, PhD:

Hello, I'm Dr. Edward Hu, cataract specialist with the Wolfe Eye Clinic in Iowa, and I wanted to share with you some results of a paper I presented at the 2023 ASCRS meeting in San Diego. I presented a paper regarding a single surgeon retrospective comparative analysis of 517 eyes in which they were broken down into two subgroups of routine cataract surgery. One group had had prior refractive surgery, either LASIK or PRK versus the second subgroup which had not had prior refractive surgery.

We analyze the outcomes in terms of vision. and understandably, preoperatively, the refractive group had slightly better visual acuities because they had undergone refractive surgery. Postoperatively, interestingly, the refractive group had slightly better visual outcomes than the patients that had not undergone refractive surgery. Our conclusion is that the monofocal IOL, with the aberration-free design of the Bausch + Lomb enVista likely had contributed to these great outcomes in both subgroups.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Extended lotilaner 0.25% therapy shows meibomian gland benefits
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Mitch Ibach, OD, FAAO, details the importance to unveiling the underlying cause of dry eye in a CCS 2025 presentation.
Steven Greenstein, MD, one of the cochairs of the Collaborative Care Symposium gave some insight into the upcoming conference and what attendees can expect.
Dr Julie Poteet reports on patient-reported outcomes using lipid-containing artificial tear
Karl Stonecipher ASCRS 2025
AnnMarie Hipsley, DPT, PhD, at ASCRS 2025
© 2025 MJH Life Sciences

All rights reserved.